Scott A. Gerber, Ph.D.

Contact Information

Phone Numbers

Administrative: (585) 275-1488

Office: (585) 276-7380

Faculty Appointments

Associate Professor - Department of Surgery , Research (SMD)
Associate Professor - Cancer Center - Joint
Associate Professor - Department of Microbiology and Immunology (SMD) - Joint
Associate Professor - Department of Radiation Oncology (SMD) - Joint

Biography

Research

Dr. Gerber is a tumor immunologist whose laboratory focuses on harnessing the immune system to recognize and kill cancerous cells. His lab uses an immunotherapeutic approach to enhance the efficacy of chemo/radiotherapies to control or even cure both primary and metastatic malignancies.

Credentials

Education

1997
BS | SUNY Coll at Fredonia
Biology

2001
MS | University of Rochester School of Medicine & Dentistry
Immunology

2005
PhD | University of Rochester School of Medicine & Dentistry
Microbiology & Immunology

Post-doctoral Training & Residency

2005 - 2008
Yale University, New Haven, CT (Mentor: Jordan Pober)

Awards

2019
National Cancer Institute R01 CA230277

2019
URMC Outstanding Graduate Student Teacher Award

2018 - 2019
University Research Award

2018
Clinical and Translational Science Institute Pilot Study Award

2017
Wilmot Cancer Institute Collaborative Award

2016
Washington University SPORE in Pancreatic Cancer Developmental Research Award

2016
UR/UB Genomics Collaborative Pilot Award

2012 - 2013
American Association of Immunologist (AAI) Early Career Faculty Travel Grant

2008
Anna Fuller Fund Fellowship in Molecular Oncology
Sponsor: Yale University
Location: New Haven, CT

2006
Vincent du Vigneaud Award for outstanding doctoral thesis
Sponsor: University of Rochester Medical Center
Location: Rochester, NY

VIEW ALL

Publications

Journal Articles

5/2023
Ye J, Gavras NW, Keeley DC, Hughson AL, Hannon G, Vrooman TG, Lesch ML, Johnston CJ, Lord EM, Belt BA, Linehan DC, Eyles J, Gerber SA. "CD73 and PD-L1 dual blockade amplifies antitumor efficacy of SBRT in murine PDAC models." Journal for immunotherapy of cancer.. 2023 May; 11(5)

4/17/2023
Hong Y, Walling BL, Kim HR, Serratelli WS, Lozada JR, Sailer CJ, Amitrano AM, Lim K, Mongre RK, Kim KD, Capece T, Lomakina EB, Reilly NS, Vo K, Gerber SA, Fan TC, Yu AL, Oakes PW, Waugh RE, Jun CD, Reagan PM, Kim M. "ST3GAL1 and ?II-spectrin pathways control CAR T cell migration to target tumors." Nature immunology.. 2023 Apr 17; Epub 2023 Apr 17.

4/16/2023
Hannon G, Lesch ML, Gerber SA. "Harnessing the Immunological Effects of Radiation to Improve Immunotherapies in Cancer." International journal of molecular sciences.. 2023 Apr 16; 24(8)Epub 2023 Apr 16.

VIEW ALL PUBLICATIONS